{"id":"W4415942701","doi":"10.1016/j.annonc.2025.08.1752","title":"1115P NRG GY012: A randomized phase II study comparing single-agent cediranib with olaparib/durvalumab, cediranib/durvalumab, and olaparib/capivasertib in women with recurrent, persistent or metastatic endometrial cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Metastatic breast cancer; Endometrial cancer; Phases of clinical research; Clinical trial; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002086867,0.002041561,0.003149507,0.0005453471,0.0004410887,0.001179411,0.001222577,0.00179573,0.009790327],"category_scores_gemma":[0.00162826,0.0009170452,0.002313252,0.0006099496,0.001373865,0.001140378,0.0004704525,0.003733227,0.001833864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001208377,"about_ca_system_score_gemma":0.001910267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00176369,"about_ca_topic_score_gemma":0.004951708,"domain_scores_codex":[0.9993623,0.000335643,0.00003471733,0.0001237955,0.00004028357,0.0001033745],"domain_scores_gemma":[0.999186,0.0001899361,0.0001422575,0.00007428945,0.00003814273,0.0003694715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9586941,0.008592284,0.001079918,0.0005262106,0.001255929,0.0000464819,0.00005348285,0.0004860262,0.003793064,0.0001607008,0.001145904,0.02416596],"study_design_scores_gemma":[0.9384096,0.05835804,0.001433413,0.00001938245,0.0004493838,0.00003959789,0.00002265543,0.000258,0.0002407403,0.0001061649,0.0006497956,0.00001318863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793029,0.005297179,0.001056712,0.001216079,0.000673073,0.005443786,0.002864666,0.0002428532,0.003902775],"genre_scores_gemma":[0.9775224,0.003799456,0.002962553,0.002016816,0.000402838,0.004098846,0.003881501,0.00005919503,0.005256364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009790327,"threshold_uncertainty_score":0.03275192,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1684586252757167,"score_gpt":0.4368037044852046,"score_spread":0.2683450792094879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}